Product Description
Teriparatide acetate is a human parathyroid hormone preparation that facilitates bone formation. (Sourced from: https://www.asahi-kasei.co.jp/asahi/en/news/2010/e101020.html)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Asahi Kasei Pharma
Company Location: TOKYO M0 1018101
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Osteoporosis
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| JapicCTI-132276 | P3 |
Completed |
Osteoporosis |
2016-03-01 |
|||
| JapicCTI-070444 | P3 |
Completed |
Osteoporosis |
None |
|||
| JapicCTI-163477 | P3 |
Completed |
Osteoporosis |
None |